This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects and safety of reducing antipsychotic dose compared to continuing the dose for people with schizophrenia. To examine factors of dose reduction such as its degree and rapidity.
No takes yet. Share an insight, caveat, or question.
Bighelli et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: